サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1248055

生体吸収性ポリマー市場：2030年までの予測

Bioresorbable polymers Market Research Report - Forecast Till 2030
出版日: | 発行: Market Research Future | ページ情報: 英文 185 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
生体吸収性ポリマー市場：2030年までの予測
出版日: 2023年03月23日
発行: Market Research Future
ページ情報: 英文 185 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生体吸収性ポリマーの市場規模は、予測期間中に12.8%のCAGRで拡大すると予測されています。生体吸収性ポリマーは、医療サービス分野、特に薬物運搬のフレームワークで広く利用されています。筋肉や歯科など、さまざまな用途で生体吸収性ポリマーが利用されることで、予測期間中に生体吸収性ポリマーへの関心が高まると予測されます。

当レポートでは、世界の生体吸収性ポリマー市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 市場調査手法

第4章 世界の生体吸収性ポリマー市場の市場力学

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • 動向・技術

第5章 世界の生体吸収性ポリマー市場の市場要因分析

  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 価格分析

世界の生体吸収性ポリマー市場、タイプ別

  • イントロダクション
  • アグロポリマー
  • バイオポリエステル

世界の生体吸収性ポリマー市場、用途別

  • イントロダクション
  • 整形外科
  • ドラッグデリバリー
  • その他

世界の生体吸収性ポリマー市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • ラテンアメリカ

企業の情勢

  • イントロダクション
  • 市場戦略
  • 主な開発分析（拡張/合併と買収/合弁事業/新製品開発/契約/投資）

企業プロファイル

  • EVONIK INDUSTRIES AG
  • CORBION NV
  • FOSTER CORPORATION
  • POLY-MED INC
  • DURECT CORPORATION
  • MERCK KGAA
  • KONINKLIJKE DSM NV
  • KLS MARTIN
  • ASHLAND
  • PUTNAM PLASTICS
  • GROUPE PCAS
  • REVA MEDICAL, INC

結論

図表

LIST OF TABLES

  • TABLE 1 GLOBAL BIORESORBABLE POLYMERS MARKET: BY REGION, 2022-2030
  • TABLE 2 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030
  • TABLE 3 EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030
  • TABLE 4 ASIA-PACIFIC: BIORESORBABLE POLYMERS MARKET. BY COUNTRY, 2022-2030
  • TABLE 5 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030
  • TABLE 6 LATIN AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030
  • TABLE 7 GLOBAL BIORESORBABLE POLYMERS TYPE MARKET, BY REGIONS, 2022-2030
  • TABLE 8 NORTH AMERICA: BIORESORBABLE POLYMERS TYPE MARKET, BY COUNTRY, 2022-2030
  • TABLE 9 EUROPE: BIORESORBABLE POLYMERS TYPE MARKET, BY COUNTRY, 2022-2030

TABLE10 ASIA-PACIFIC: BIORESORBABLE POLYMERS TYPE MARKET, BY COUNTRY, 2022-2030

TABLE11 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS TYPE MARKET, BY COUNTRY, 2022-2030

TABLE12 LATIN AMERICA: BIORESORBABLE POLYMERS TYPE MARKET, BY COUNTRY, 2022-2030

TABLE13 GLOBAL BIORESORBABLE POLYMERS APPLICATION MARKET, BY REGIONS, 2022-2030

TABLE14 NORTH AMERICA: BIORESORBABLE POLYMERS APPLICATION MARKET, BY COUNTRY, 2022-2030

TABLE15 EUROPE: BIORESORBABLE POLYMERS APPLICATION MARKET, BY COUNTRY, 2022-2030

TABLE16 ASIA-PACIFIC: BIORESORBABLE POLYMERS APPLICATION MARKET, BY COUNTRY, 2022-2030

TABLE17 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS APPLICATION MARKET, BY COUNTRY, 2022-2030

TABLE18 LATIN AMERICA: BIORESORBABLE POLYMERS BY APPLICATION MARKET, BY COUNTRY, 2018-2025

TABLE19 GLOBAL TYPE MARKET, BY REGION, 2022-2030

TABLE20 GLOBAL APPLICATION MARKET, BY REGION, 2022-2030

TABLE21 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030

TABLE22 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030

TABLE23 NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2022-2030

TABLE24 EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030

TABLE25 EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030

TABLE26 EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2022-2030

TABLE27 ASIA-PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030

TABLE28 ASIA-PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030

TABLE29 ASIA-PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2022-2030

TABLE30 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030

TABLE31 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030

TABLE32 MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2022-2030

TABLE33 LATIN AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2022-2030

TABLE34 LATIN AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030

TABLE35 LATIN AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2022-2030

LIST OF FIGURES

  • FIGURE 1 GLOBAL BIORESORBABLE POLYMERS MARKET SEGMENTATION
  • FIGURE 2 FORECAST RESEARCH METHODOLOGY
  • FIGURE 3 FIVE FORCES ANALYSIS OF GLOBAL BIORESORBABLE POLYMERS MARKET
  • FIGURE 4 VALUE CHAIN OF GLOBAL BIORESORBABLE POLYMERS MARKET
  • FIGURE 5 GLOBAL BIORESORBABLE POLYMERS MARKET, 2022-2030, BY COUNTRY, 2020
  • FIGURE 6 SHARE OF GLOBAL BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030
  • FIGURE 7 GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY TYPE, 2020
  • FIGURE 8 SHARE OF GLOBAL BIORESORBABLE POLYMERS MARKET, BY TYPE, 2022-2030
  • FIGURE 9 GLOBAL BIORESORBABLE POLYMERS MARKET SIZE, BY APPLICATION, 2020

FIGURE10 SHARE OF GLOBAL BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2022-2030

目次
Product Code: MRFR/CnM/0463-CR

Market Overview

The bioresorbable polymers Market is projected to build a CAGR of 12.8% during the forecast time frame. Bioresorbable polymers are broadly utilized in the medical services sector, particularly in the medication conveyance framework. The utilization of bioresorbable polymers in different applications, for example, muscular and dental is projected to help the interest in bioresorbable polymers during the forecast time frame. The utilization of bioresorbable polymers is prospering in the medical services industry as would be considered normal to drive the bioresorbable polymers market before very long.

Polymers have altogether added to the improvement of medication conveyance innovation by empowering the directed arrival of restorative specialists in steady doses overstretched periods, cyclic dosing, and different arrivals of both hydrophilic and hydrophobic drugs. The region has extended altogether from its beginning of utilizing normal materials. The sane plan of polymers made to apply specific organic exercises and customized for a particular freight is presently the establishment for contemporary headways in drug conveyance.

In polymer treatments and nanomedicines, polymers have been utilized widely. Strong, for the most part round structures produced using natural or manufactured polymers are known as polymeric nanoparticles. One of the main natural purposes of polymeric nanoparticles is drug conveyance. An assortment of medication conveyance frameworks, including small hydrophilic and hydrophobic drugs, immunizations, peptides, and natural macromolecules, have been tried to convey polymeric nanoparticles. The biodegradable polymers that produce polymeric nanoparticles most effectively incorporate different grades of poly(lactide-co-glycolide) and poly(lactide) copolymers.

Market Segmentation

Based on Type, the Bioresorbable polymers market type, includes agro-polymer and bio-polyesters. Based on application, the market is classified into orthopedic, drug delivery, biodegradable devices, and others.

Regional Insights

North America overwhelmed the market with a portion of 44.03%, representing USD 578.60 million in 2021; it is normal to enlist the most noteworthy CAGR of 12.60% from 2022 to 2030. Europe was the second biggest with a portion of 25.92% in 2021, estimated at USD 340.59 million; it is projected to show a CAGR of 11.9%. The North American market is essentially determined by the accessibility of unrefined components and expanding interest in bioresorbable polymers across the region for different applications in clinical, drug, and others. Because of financial changes and expanded per capita pay, the medical services sector is growing all through North America, including the US and Canada.

Europe represents the second-biggest market share Bioresorbable polymers market is to a great extent provided by European nations like the UK and Germany. The developing interest in drug conveyance frameworks in the region is probably going to help the interest in the Bioresorbable polymers market. Further, the Germany Bioresorbable polymers market held the biggest market share and the quickest-developing market in the European region.

Major Players

Key Companies in the Bioresorbable polymers market are Evonik Industries AG, Corbion NV, Foster Corporation, Poly-Med Inc., REVA Medical, Inc. Groupe PCAS, Merck KGaA, Koninklijke DSM N.V, KLS Martin, and Ashland.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 MARKET DEFINITION
  • 2.2 SCOPE OF THE STUDY
    • 2.2.1 RESEARCH OBJECTIVES
    • 2.2.2 ASSUMPTIONS & LIMITATIONS
  • 2.3 MARKETS STRUCTURE
  • 2.4 KEY TAKEAWAYS

3 MARKET RESEARCH METHODOLOGY

  • 3.1 RESEARCH PROCESS
  • 3.2 PRIMARY RESEARCH
  • 3.3 SECONDARY RESEARCH
  • 3.4 MARKET SIZE ESTIMATION
  • 3.5 FORECAST MODEL

4 MARKET DYNAMICS OF GLOBAL BIORESORBABLE POLYMERS MARKET

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
  • 4.3 RESTRAINTS
  • 4.4 OPPORTUNITIES
  • 4.5 CHALLENGES
  • 4.6 TRENDS/TECHNOLOGY

5 MARKET FACTOR ANALYSIS OF GLOBAL BIORESORBABLE POLYMERS MARKET

  • 5.1 SUPPLY CHAIN ANALYSIS
    • 5.1.1 RAW MATERIAL SUPPLIERS
    • 5.1.2 MANUFACTURERS/PRODUCERS
    • 5.1.3 DISTRIBUTORS/RETAILERS/WHOLESALERS/E-COMMERCE
    • 5.1.4 END USER
  • 5.2 PORTER'S FIVE FORCES ANALYSIS
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 BARGAINING POWER OF SUPPLIERS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.3 PRICING ANALYSIS

GLOBAL BIORESORBABLE POLYMERS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 AGRO-POLYMERS
    • 6.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 6.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.2.2.1 PROTEINS
      • 6.2.2.1.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.2.2.1.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.2.2.2 POLYSACCHARIDES
      • 6.2.2.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.2.2.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
  • 6.3 BIO-POLYESTERS
    • 6.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 6.3.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.3.2.1 POLYGLYCOLIC ACID
      • 6.3.2.1.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.3.2.1.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.3.2.2 POLYLACTIC ACID
      • 6.3.2.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.3.2.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.3.2.3 POLYCAPROLACTONE
      • 6.3.2.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.3.2.3.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.3.2.4 POLYDIOXANONE
      • 6.3.2.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.3.2.4.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
      • 6.3.2.5 OTHERS
      • 6.3.2.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 6.3.2.5.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030

GLOBAL BIORESORBABLE POLYMERS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 ORTHOPEDICS
    • 7.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 7.2.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
  • 7.3 DRUG DELIVERY
    • 7.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 7.3.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030
  • 7.4 OTHERS
    • 7.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 7.4.2 MARKET ESTIMATES & FORECAST, BY REGION, 2022-2030

GLOBAL BIORESORBABLE POLYMERS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 8.2.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
    • 8.2.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.2.4 US
      • 8.2.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.2.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.2.4.3 MARKET ESTIMATES & FORECAST, APPLICATION, 2022-2030
    • 8.2.5 CANADA
      • 8.2.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.2.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.2.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
  • 8.3 EUROPE
    • 8.3.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 8.3.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
    • 8.3.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.4 GERMANY
      • 8.3.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.3.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.5 FRANCE
      • 8.3.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.3.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.6 ITALY
      • 8.3.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.3.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.7 SPAIN
      • 8.3.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.7.2 MARKET ESTIMATES & FORECAST, BY TYPE,2022-2030
      • 8.3.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.8 UK
      • 8.3.8.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.8.2 MARKET ESTIMATES & FORECAST, BY TYPE,2022-2030
      • 8.3.8.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.9 RUSSIA
      • 8.3.9.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.9.2 MARKET ESTIMATES & FORECAST, BY TYPE,2022-2030
      • 8.3.9.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.10 POLAND
      • 8.3.10.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.10.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.3.10.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.3.11 REST OF EUROPE
      • 8.3.11.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.3.11.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.3.11.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
  • 8.4 ASIA-PACIFIC
    • 8.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 8.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
    • 8.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.4.4 CHINA
      • 8.4.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.4.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.4.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.4.5 INDIA
      • 8.4.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.4.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.4.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.4.6 JAPAN
      • 8.4.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.4.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.4.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.4.7 AUSTRALIA & NEW ZEALAND
      • 8.4.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.4.7.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.4.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.4.8 REST OF ASIA-PACIFIC
      • 8.4.8.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.4.8.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.4.8.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
  • 8.5 MIDDLE EAST & AFRICA
    • 8.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 8.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
    • 8.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.5.4 GCC
      • 8.5.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.5.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.5.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.5.5 ISRAEL
      • 8.5.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.5.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.5.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.5.6 NORTH AFRICA
      • 8.5.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.5.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.5.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.5.7 TURKEY
      • 8.5.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.5.7.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.5.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.5.8 REST OF MIDDLE EAST & AFRICA
      • 8.5.8.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.5.8.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.5.8.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
  • 8.6 LATIN AMERICA
    • 8.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
    • 8.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
    • 8.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.6.4 BRAZIL
      • 8.6.4.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.6.4.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.6.4.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.6.5 ARGENTINA
      • 8.6.5.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.6.5.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.6.5.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.6.6 MEXICO
      • 8.6.6.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.6.6.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.6.6.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030
    • 8.6.7 REST OF LATIN AMERICA
      • 8.6.7.1 MARKET ESTIMATES & FORECAST, 2022-2030
      • 8.6.7.2 MARKET ESTIMATES & FORECAST, BY TYPE, 2022-2030
      • 8.6.7.3 MARKET ESTIMATES & FORECAST, BY APPLICATION, 2022-2030

COMPANY LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET STRATEGY
  • 9.3 KEY DEVELOPMENT ANALYSIS (EXPANSION/MERGER & ACQUISITIONS/JOINT VENTURE/NEW PRODUCT DEVELOPMENT/AGREEMENT/INVESTMENT)

COMPANY PROFILES

  • 10.1 EVONIK INDUSTRIES AG
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL UPDATES
    • 10.1.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.1.4 STRATEGY
    • 10.1.5 KEY DEVELOPMENTS
    • 10.1.6 SWOT ANALYSIS
  • 10.2 CORBION NV
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL UPDATES
    • 10.2.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.2.4 STRATEGY
    • 10.2.5 KEY DEVELOPMENTS
    • 10.2.6 SWOT ANALYSIS
  • 10.3 FOSTER CORPORATION.
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL UPDATES
    • 10.3.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.3.4 STRATEGY
    • 10.3.5 KEY DEVELOPMENTS
    • 10.3.6 SWOT ANALYSIS
  • 10.4 POLY-MED INC.
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL UPDATES
    • 10.4.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.4.4 STRATEGY
    • 10.4.5 KEY DEVELOPMENTS
    • 10.4.6 SWOT ANALYSIS
  • 10.5 DURECT CORPORATION
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL UPDATES
    • 10.5.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.5.4 STRATEGY
    • 10.5.5 KEY DEVELOPMENTS
    • 10.5.6 SWOT ANALYSIS
  • 10.6 MERCK KGAA
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL UPDATES
    • 10.6.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.6.4 STRATEGY
    • 10.6.5 KEY DEVELOPMENTS
    • 10.6.6 SWOT ANALYSIS
  • 10.7 KONINKLIJKE DSM N.V
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL UPDATES
    • 10.7.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.7.4 STRATEGY
    • 10.7.5 KEY DEVELOPMENTS
    • 10.7.6 SWOT ANALYSIS
  • 10.8 KLS MARTIN
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL UPDATES
    • 10.8.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.8.4 STRATEGY
    • 10.8.5 KEY DEVELOPMENTS
    • 10.8.6 SWOT ANALYSIS
  • 10.9 ASHLAND
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL UPDATES
    • 10.9.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.9.4 STRATEGY
    • 10.9.5 KEY DEVELOPMENTS
    • 10.9.6 SWOT ANALYSIS
  • 10.10 PUTNAM PLASTICS
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL UPDATES
    • 10.10.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.10.4 STRATEGY
    • 10.10.5 KEY DEVELOPMENTS
    • 10.10.6 SWOT ANALYSIS
  • 10.11 GROUPE PCAS
    • 10.11.1 COMPANY OVERVIEW
    • 10.11.2 FINANCIAL UPDATES
    • 10.11.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.11.4 STRATEGY
    • 10.11.5 KEY DEVELOPMENTS
    • 10.11.6 SWOT ANALYSIS
  • 10.12 REVA MEDICAL, INC
    • 10.12.1 COMPANY OVERVIEW
    • 10.12.2 FINANCIAL UPDATES
    • 10.12.3 PRODUCT/BUSINESS SEGMENT OVERVIEW
    • 10.12.4 STRATEGY
    • 10.12.5 KEY DEVELOPMENTS
    • 10.12.6 SWOT ANALYSIS

CONCLUSION